Skip to main content

Home/ Groups/ Dr. Goodyear
2More

Peripheral metabolism of thyroid hormones: a revie... [Altern Med Rev. 2000] - PubMed r... - 0 views

  • The common feature of these disorders is a low level of circulating T3, with generally normal to slightly elevated blood T4 levels and either normal or slightly suppressed TSH levels. This pattern of altered thyroid hormone levels is generally agreed to be a result of impairment in extra-thyroidal peripheral metabolism
  •  
    thyroid replacement is not just about T4 (synthroid); but about T3, which is 5.4 x more potent
1More

The Role of Selenium in Thyroid Hormone Action -- BERRY and LARSEN 13 (2): 207 -- Endoc... - 0 views

  •  
    selenium deficiency results in low thyroid function: yes a mineral.
2More

[Functional states of pituitary-ovary, adrenal and... [Zhonghua Fu Chan Ke Za Zhi. 1998... - 0 views

  • CONCLUSION: It appears that ovarian androgen excess in women with PCOS is mainly LH-dependent in Group 1 and insulin-dependent in Group 2. Enhanced adrenal activity may contribute to both hyperandrogenism and insulin resistance in this syndrome, and subclinical hypothyroidism may exist in affected subjects, especially of Group 1.
  •  
    PCOS is not a birth control pill deficiency, but a complex hormonal imbalance
1More

Thyroid Hormone Replacement - One Hormone or Two? - NEJM - 0 views

  •  
    Patients feel better taking both T4 and T3 compared to those taking just T4
2More

Long-lived mitochondrial (Mit) mutants of Caenorhabditis elegans utilize a novel metabo... - 0 views

  • Our study suggests long-lived, genetically specified Mit mutants employ a novel metabolism and that life span may well arise as a function of metabolic state.
  •  
    Mitchondria, metabolism,  and aging
2More

Clinical controversies in screening women for thyr... [J Midwifery Womens Health. 2006 ... - 0 views

  • In November 2002, the American Association of Clinical Endocrinologists (AACE) released new guidelines for clinical practice for the diagnosis and treatment of hyperthyroidism and hypothyroidism, which includes a new thyroid-stimulating hormone (TSH) reference range of 0.3 to 3.0 mIU/
  •  
    TSH "screening" needs to be between 0.3 and 3 according to American Association of Clinical Endocrinologists
2More

Subclinical Thyroid Dysfunction: A Joint Statement on Management from the American Asso... - 0 views

  • the potential benefits of early detection and treatment of subclinical thyroid dysfunction significantly outweigh the potential side-effects that could result from early diagnosis and therapy
  •  
    Joint statement on early treatment of thyroid disease and subclinical thyroid dysfunction from The american association of clinical endocrinologists, the American Thyroid Association, and the Endocrine Society
2More

TSH may not be a good marker for adequate thyroid ... [Wien Klin Wochenschr. 2005] - Pu... - 0 views

  • TSH levels used to monitor substitution, mostly regulated by intracellular T3 in the pituitary, may not be such a good indicator of adequate thyroid hormone action in all tissues
  •  
    TSH may not be a good marker for adequate thyroid hormone replacement therapy.
1More

Omega Research - 0 views

  •  
    omega-3 limit amyloid and oxidative damage; thus may decrease alzheimer's disease risk
2More

Environmental Lead Exposure and Progression of Chronic Renal Diseases in Patients witho... - 0 views

  • Low-level environmental lead exposure may accelerate progressive renal insufficiency in patients without diabetes who have chronic renal disease. Repeated chelation therapy may improve renal function and slow the progression of renal insufficiency
  •  
    EDTA chelation aids in lead induced chronic renal insufficiency
2More

The Toxicology of Mercury - Current Exposures and Clinical Manifestations - NEJM - 0 views

  • The Toxicology of Mercury — Current Exposures and Clinical Manifestations
  •  
    Nice review of the toxicology of Mercury
2More

Lead-Chelation Therapy -- A Treatment for Chronic Renal Disease? - General Medicine - 1 views

  • Therapy with EDTA delayed the progression of chronic renal insufficiency in patients with high-normal body lead burdens
  •  
    Therapy with EDTA delayed the progression of chronic renal insufficiency in patients with high-normal body lead burdens
3More

Effects of ethyl-eicosapentaenoic acid omega-3 fat... [Menopause. 2009 Mar-Apr] - PubMe... - 0 views

  • Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.
  • Supplementation with E-EPA omega-3 fatty acid reduced HF frequency and improved the HF score relative to placebo
  •  
    omega-3 aids in hot flash relief
2More

Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive ... - 0 views

  • he 8-wk changes in PD and depressive scales improved significantly more with E-EPA than with placebo.
  •  
    omega-3 improves depressive and psychological distress symptoms
2More

Omega Research - 0 views

  • These data have important implications for the supplementation of a combination of omega-3 fatty acids and antioxidants in the successful management of female infertility.
  •  
    omega 3 and antioxidants aid in infertility
1More

Omega Research - 0 views

  •  
    higher omega-3 intake = lower type 2 diabetes
2More

Insulin Receptor Expression and Function in Human Breast Cancer Cell Lines - Cancer Res - 0 views

  • This present study indicates therefore that in breast cancer cell lines there are functional insulin receptors that regulate breast cancer cell growth.
  •  
    breast cancer cells express high functioning insulin receptors
1More

The syndrome of irreversible lithium-effectuated n... [Clin Neuropharmacol. 2005 Jan-Fe... - 0 views

  •  
    Silent but irreversible lithium-induced neurotoxicity
2More

Antipsychotic drug use and mortality in older adul... [Ann Intern Med. 2007] - PubMed r... - 0 views

  • Atypical antipsychotic use is associated with an increased risk for death compared with nonuse among older adults with dementia
  •  
    up to 1.55 x increase risk of death with antipsychotic use
2More

Predicting the long-term risk of tardive dyskinesi... [J Clin Psychiatry. 1993] - PubMe... - 0 views

  • , we estimate the risk of persistent TD to be 32% after 5 years of neuroleptic exposure (95% confidence interval [CI] = 23%-43%), 57% after 15 years of exposure (95% CI = 47%-66%), and 68% after 25 years of exposure
  •  
    Neuroleptics significantly increase risk of Tardive Dyskinesias: we should think before we prescribe
« First ‹ Previous 10961 - 10980 of 11108 Next › Last »
Showing 20 items per page